Variant report
Variant | esv3393195 |
---|---|
Chromosome Location | chr10:53716196-53718044 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565934811 | chr10:53716282-53716283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73339223 | chr10:53716402-53716403 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs115754647 | chr10:53716416-53716417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140789817 | chr10:53716423-53716424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376800840 | chr10:53716449-53716450 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4935295 | chr10:53716463-53716464 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs10664486 | chr10:53716472-53716473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10665520 | chr10:53716473-53716474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs71785773 | chr10:53716479-53716480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200235049 | chr10:53716482-53716483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575298681 | chr10:53716489-53716490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190735421 | chr10:53716492-53716493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536819393 | chr10:53716500-53716501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553313828 | chr10:53716517-53716518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12411770 | chr10:53716542-53716543 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs545305883 | chr10:53716570-53716571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182635453 | chr10:53716585-53716586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187906663 | chr10:53716596-53716597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544280973 | chr10:53716605-53716606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368593482 | chr10:53716618-53716619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192426967 | chr10:53716631-53716632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530154344 | chr10:53716656-53716657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143725296 | chr10:53716704-53716705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs398114330 | chr10:53716705-53716706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541418913 | chr10:53716711-53716712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577593385 | chr10:53716735-53716736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549112872 | chr10:53716761-53716762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376906973 | chr10:53716788-53716789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562135273 | chr10:53716794-53716795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199822568 | chr10:53716822-53716823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73339224 | chr10:53716823-53716824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs149462049 | chr10:53716867-53716868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374262191 | chr10:53716868-53716869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545045200 | chr10:53716882-53716883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558828217 | chr10:53716884-53716885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146554859 | chr10:53716885-53716886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564496587 | chr10:53716911-53716912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71489334 | chr10:53716913-53716914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71489335 | chr10:53716915-53716916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71489336 | chr10:53716917-53716918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146269300 | chr10:53716919-53716920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143641070 | chr10:53716920-53716921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10823914 | chr10:53716934-53716935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551744897 | chr10:53716947-53716948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10823915 | chr10:53716969-53716970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115858902 | chr10:53716973-53716974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550609239 | chr10:53716977-53716978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386743688 | chr10:53716992-53716993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs386743689 | chr10:53716996-53716997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148628791 | chr10:53717009-53717010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Cancer | 20164920 | CNVD |
Ollier disease | 21235737 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:53711000-53720400 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr10:53713400-53720600 | Weak transcription | Fetal Stomach | stomach |
3 | chr10:53713400-53742400 | Weak transcription | Aorta | Aorta |
4 | chr10:53713800-53720400 | Weak transcription | Rectal Smooth Muscle | rectum |
5 | chr10:53714400-53716400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr10:53714600-53716600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr10:53715200-53720400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr10:53715800-53716400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr10:53715800-53716600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr10:53715800-53720000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr10:53715800-53720400 | Weak transcription | Brain Anterior Caudate | brain |
12 | chr10:53716000-53720400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr10:53716000-53720400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
14 | chr10:53716000-53720400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr10:53716000-53720400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
16 | chr10:53716000-53720400 | Weak transcription | NHDF-Ad | bronchial |
17 | chr10:53716400-53719800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
18 | chr10:53716400-53720400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
19 | chr10:53716600-53716800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr10:53716600-53719800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
21 | chr10:53716600-53720400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |